RxDoctor Payments Data

Makoto Kawai, MD

Sleep Medicine · Palo Alto, CANPI 1215175856

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $996 of the $996 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Fukuda Denshi Co., Ltd.. That places this record below the midpoint for sleep medicine clinicians in CA, where the typical reported total is $1,477.

$996in general payments, 2019–2025

Across 1 payment — averaging $995.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fukuda Denshi Co., Ltd.$996
$140,257in research payments, 2019–2025

Across 3 payments — averaging $46,752 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Functional Neuromodulation Inc$140K

What the payments were for

  • Speaking & faculty fees$996100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Fukuda Denshi Co., Ltd.1$996

How this compares

$996 in reported general payments places this provider in the 45th percentile of 200 sleep medicine providers in California.

See all sleep medicine providers in California

Medicare billing

Part B allowed, 2024
$103,589
Medicare patients
453
Services billed
678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelsomraSuvorexant16$6,783
Modafinil14$497
Eszopiclone15$390
Gabapentin26$318
Zolpidem Tartrate29$301
Trazodone Hcl21$240
Methadone Hcl17$232
Methylphenidate Hcl13$132
Ropinirole Hcl12$47

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →